The specific immunogen used to produce this antibody is proprietary information.

NDRG1 (Phospho Thr346) antibody detects endogenous levels of Human Mouse Rat NDRG1 (phospho-Thr346) .The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):SHtSE

NDRG1 CAP43 DRG1 RTP

NDRG1 (Thr346)

Protein NDRG1 ;
Differentiation-related gene 1 protein ;
DRG-1 ;
N-myc downstream-regulated gene 1 protein ;
Nickel-specific induction protein Cap43 ;
Reducing agents and tunicamycin-responsive protein ;
RTP ;
Rit42 ;

This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein involved in stress responses , hormone responses , cell growth , and differentiation. The encoded protein is necessary for p53-mediated caspase activation and apoptosis. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4D , and expression of this gene may be a prognostic indicator for several types of cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq , May 2012] ,

Disease:Defects in NDRG1 are the cause of Charcot-Marie-Tooth disease type 4D (CMT4D) [MIM:601455]; also known as hereditary motor and sensory neuropathy Lom type (HMSNL) . CMT4D is a recessive form of Charcot-Marie-Tooth disease , the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy and primary peripheral axonal neuropathy. Demyelinating CMT neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec) , segmental demyelination and remyelination with onion bulb formations on nerve biopsy , slowly progressive distal muscle atrophy and weakness , absent deep tendon reflexes , and hollow feet. By convention , autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. ,Function:May have a growth inhibitory role. ,induction:By homocysteine , 2-mercaptoethanol , tunicamycin in endothelial cells. Induced approximately 20-fold during in vitro differentiation of the colon carcinoma cell lines HT29-D4 and Caco-2. Induced by nickel compounds in all tested cell lines. The primary signal for its induction is an elevation of free intracellular calcium ion caused by nickel ion exposure. Okadaic acid , a serine/threonine phosphatase inhibitor , induced its expression more rapidly and more efficiently than nickel. ,similarity:Belongs to the NDRG family. ,subcellular location:Whereas in prostate epithelium and placental chorion it is located in both the cytoplasm and the nucleus , nuclear staining is not observed in colon epithelium cells. Instead its localization changes from the cytoplasm to the plasma membrane during differentiation of colon carcinoma cell lines in vitro. ,tissue specificity:Ubiquitous; expressed most prominently in placental membranes and prostate , kidney , small intestine , and ovary tissues. Reduced expression in adenocarcinomas compared to normal tissues. In colon , prostate and placental membranes , the cells that border the lumen show the highest expression. ,

Cytoplasm , cytosol. Cytoplasm , cytoskeleton , microtubule organizing center , centrosome. Nucleus. Cell membrane. Mainly cytoplasmic but differentially localized to other regions. Associates with the plasma membrane in intestinal epithelia and lactating mammary gland. Translocated to the nucleus in a p53/TP53-dependent manner. In prostate epithelium and placental chorion , located in both the cytoplasm and in the nucleus. No nuclear localization in colon epithelium cells. In intestinal mucosa , prostate and renal cortex , located predominantly adjacent to adherens junctions. Cytoplasmic with granular staining in proximal tubular cells of the kidney and salivary gland ducts. Recruits to the membrane of recycling/sorting and late endosomes via binding to phosphatidylinositol 4-phosphate. Associates with microtubules. Colocalizes with TUBG1 in the centrosome. Cytoplasmic location increased with hypoxia. Phosphorylated form found associated with centromeres during S-phase of mitosis and with the plasma membrane.